Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Equity (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Return on Equity for 12 consecutive years, with 0.36% as the latest value for Q1 2026.

  • For Q1 2026, Return on Equity rose 23.0% year-over-year to 0.36%; the TTM value through Mar 2026 reached 0.36%, up 23.0%, while the annual FY2025 figure was 0.56%, 22.0% up from the prior year.
  • Return on Equity hit 0.36% in Q1 2026 for Wave Life Sciences, up from 0.64% in the prior quarter.
  • Across five years, Return on Equity topped out at 134.32% in Q4 2023 and bottomed at 11.57% in Q3 2022.
  • Average Return on Equity over 5 years is 6.37%, with a median of 0.64% recorded in 2025.
  • Year-over-year, Return on Equity surged 12780bps in 2023 and then crashed -13487bps in 2024.
  • Wave Life Sciences' Return on Equity stood at 6.52% in 2022, then surged by 1959bps to 134.32% in 2023, then plummeted by -100bps to 0.55% in 2024, then fell by -15bps to 0.64% in 2025, then skyrocketed by 44bps to 0.36% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.36%, 0.64%, and 0.92% for Q1 2026, Q4 2025, and Q3 2025 respectively.